Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.

Neuro-oncology·2025
Same author

Liquid biopsies for the monitoring of gliomas and brain metastases in adults.

Acta neuropathologica·2025
Same author

Combinatorial Analysis of miRNAs and tRNA Fragments as Potential Biomarkers for Cancer Patients in Liquid Biopsies.

Non-coding RNA·2025
Same author

Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic.

Multiple sclerosis (Houndmills, Basingstoke, England)·2024
Same author

Glioblastoma, IDH-wildtype with primarily leptomeningeal localization diagnosed by nanopore sequencing of cell-free DNA from cerebrospinal fluid.

Acta neuropathologica·2024
Same author

Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study.

Neuro-oncology·2024

Related Experiment Video

Updated: Feb 23, 2026

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.8K

Platelet RNA in Cancer Diagnostics.

Lee-Ann Tjon-Kon-Fat1, Nik Sol2, Thomas Wurdinger3,4

  • 1Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden.

Seminars in Thrombosis and Hemostasis
|September 15, 2017
PubMed
Summary

Platelets play a key role in cancer metastasis by interacting with tumor cells and altering their RNA. Analyzing platelet biomarkers offers insights into cancer detection, type, and treatment selection for precision medicine.

More Related Videos

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.2K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.5K

Related Experiment Videos

Last Updated: Feb 23, 2026

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.8K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.2K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.5K

Area of Science:

  • Oncology
  • Hematology
  • Molecular Biology

Background:

  • Platelets are integral to cancer metastasis, interacting with tumor cells and their microenvironment.
  • This interaction leads to tumor-mediated 'education' of platelets, altering their RNA profiles and biomolecular content.

Purpose of the Study:

  • To explore the potential of platelets as a diagnostic and prognostic tool in oncology.
  • To investigate the utility of platelet RNA profiles and tumor-derived biomarkers for cancer detection and treatment selection.

Main Methods:

  • Analysis of platelet RNA profiles.
  • Direct measurement of tumor-derived biomarkers within platelets.

Main Results:

  • Platelet RNA profiles and biomarkers reflect ongoing cancer-related processes.
  • This analysis can inform about cancer presence, tumor type, and potentially identify oncogenic drivers.

Conclusions:

  • Platelets serve as a valuable biosource for precision medicine due to their interaction with cancer.
  • Assessing platelet biomarkers offers a promising avenue for non-invasive cancer diagnostics and personalized treatment strategies.